Investigates PBM's effects on neuronal organoid formation from stem cells, suggesting therapeutic potential.
The ability to regulate stem cell differentiation into organized neural tissue remains a major challenge in regenerative medicine, particularly in the development of physiologically relevant three-dimensional (3D) organoid models. Photobiomodulation (PBM) is a new non-invasive technology for controlling cellular metabolism and differentiation using light-mediated signalling pathways; however, its role in neural organoid development remains insufficiently understood. This study investigated the effects of PBM on the differentiation of adipose-derived mesenchymal stem cells (ADMSCs) into neuronal organoid-like structures using a 3D culture system. Immortalized ADMSCs were exposed to 525 nm and 825 nm wavelengths, individually and in combination, at fluences of 5 and 10 J/cm 2 . PBM’s effects were assessed using morphological assessment, cell viability, ATP-based metabolic activity, mitochondrial membrane potential (ΔΨm), and neural gene expression. PBM treatment affected organoid morphology, metabolic activity, and mitochondrial function in a dose- and wavelength-dependent way. Low-fluence irradiation (5 J/cm 2 ), especially at 525 nm, promotes stem cell maintenance and early neural development, as evidenced by enhanced expression of progenitor and neuronal markers. Higher fluence (10 J/cm 2 ) inhibited early differentiation responses, but mixed wavelength therapy promoted late-stage neuronal maturation with increased RBFOX3 gene expression. These findings indicate PBM as a viable method for controlling stem cell destiny and improving neuronal organoid formation for neuroregenerative applications.
No takes yet. Share an insight, caveat, or question.
Mulaudzi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: